Dr. Charlene Fell, University of Calgary, Calgary, AB

As interstitial lung diseases advance, patients suffer from progressive, debilitating, and distressing dyspnea and cough. In this session, you will learn about the mechanisms driving dyspnea and cough, non-pharmacologic and pharmacologic techniques to address these symptoms in patients with advanced ILD, and the evidence supporting these practices. Medication side effects and potential pitfalls will also be addressed. A collaborative and multidisciplinary approach to managing dyspnea and cough in the patient with advanced ILD will be emphasized.

Learning Objectives

At the end of this presentation, attendees will be able to:

  • identify the physiologic mechanisms behind dyspnea and cough in patients with advanced ILD;
  • propose non-pharmacologic and pharmacologic strategies to manage dyspnea and cough in patients with advanced ILD;
  • discuss the advantages of a multidisciplinary approach to managing dyspnea and cough in patients with advanced ILD.